CN107641653A - MACC1 AS1 probes are preparing the application in being used to predict the diagnostic reagent of stomach cancer clinical prognosis - Google Patents
MACC1 AS1 probes are preparing the application in being used to predict the diagnostic reagent of stomach cancer clinical prognosis Download PDFInfo
- Publication number
- CN107641653A CN107641653A CN201710983316.0A CN201710983316A CN107641653A CN 107641653 A CN107641653 A CN 107641653A CN 201710983316 A CN201710983316 A CN 201710983316A CN 107641653 A CN107641653 A CN 107641653A
- Authority
- CN
- China
- Prior art keywords
- macc1
- stomach cancer
- probes
- prognosis
- cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The invention belongs to the function and application field of gene and RNA, is related to MACC1 AS1 probes and is preparing the application in being used to predict the diagnostic reagent of stomach cancer clinical prognosis.The present invention also provides a kind of diagnostic kit for being used to predict stomach cancer clinical prognosis, and the kit includes MACC1 AS1 probes.The invention firstly discloses in stomach cancer, MACC1 AS1 are related to patients with gastric cancer prognosis, with patient clinical by stages, TNM stage positive correlation;Be stomach cancer cell sugar-free stress when, produce polyphenoils maintain redox equilibrium, promote glycolysis carry out maintenance glycometabolism, survive reduce apoptosis important molecule.Therefore, the present invention provides theoretical foundation and Clinical Basis for research patients with gastric cancer clinical prognosis correlative factor, for the clinical practice of non-coding RNA.
Description
Technical field
The invention belongs to the function and application field of gene and RNA, it is related to MACC1-AS1 application, more particularly to
MACC1-AS1 probes are preparing the application in being used to predict the diagnostic reagent of stomach cancer clinical prognosis.
Background technology
Stomach cancer is the malignant tumour of the death rate second in global range, and evil is occupied in the morbidity and mortality of Chinese stomach cancer
Property tumour ranking front three.And due to early gastric caacer symptom unobvious, the Patients with Gastric Cancer more than 2/3 has been late in first visit
Phase.It is various currently for the medicament categories of chemotherapy of gastric cancer, such as:Alkylating agent, antimetabolite and topoisomerase enzyme inhibitor etc..But
The classic chemotherapy Regimen Chemotherapy overall reaction rate (overall response rate, ORR) of late gastric cancer only >=40%, give birth to by middle position
Phase 8- is deposited 10 months, even if joint targeted therapy, median survival interval only extend to 13.8 months.Meanwhile chemotherapy of gastric cancer curative effect is different
Matter is higher, although Partial tumors mark can react gastric cancer tumor load and treatment curative effect, still remain to be discovered prediction at present
The index and its detection method of patients with gastric cancer clinical prognosis.So finding early diagnosis and the method for prognosis of simplicity, excavate new
Anti-gastric cancer medicament is still to capture stomach cancer urgent problem to be solved at present.
Energetic supersession restructuring is that malignant cell is different from one of 10 big features of normal cell.In normal cell,
Glucose is most important Energy supply material, and sugared aerobic oxidation is most important energy supply approach.And in many malignant cells
In, ATP caused by aerobic glycolysis (Warburg effects) is even as high as 60%, and its glycolysis level is the 20- of normal cell
30 times.Because malignant cell has the feature of infinite multiplication, the environment of tumor by local relatively hypoxia promotes tumour cell
Metabolism is recombinated to tackle the stress situation of energy deficiency.AMPK (AMP-activated protein kinase) is intracellular weight
The energy receptor wanted, AMPK can be activated when intracellular AMP/ATP ratios raise, promote cell to start synthesis ATP decomposition
Metabolic process, such as glycolysis, also controllable pentose phosphate pathway is so as to producing NADPH with balance oxidation reducing condition.Existing text
Report is offered, under the conditions of glucose deprivation, AMPK can pass through MACC1 (metastasis-associated in colon
Cancer-1 stomach cancer cell) is regulated and controled by glycolytic pathway capacitation, this further prompts related-metabolism index is possible can conduct
Clinical patients with gastric cancer assesses one of index of prognosis.
MACC1-AS1 (NR_046756) is long-chain non-coding RNA (the long noncoding positioned at MACC1 antisense strands
RNA, lnc RNA), there is not yet this lnc RNA correlation function research reports in malignant tumour.
The content of the invention
It is an object of the invention to provide the new opplication of MACC1-AS1 probes, specifically MACC1-AS1 probes are preparing use
Application in the diagnostic reagent of prediction stomach cancer clinical prognosis.
Preferably, the MACC1-AS1 probes include such as SEQ ID NO:Nucleotide sequence shown in 1.
Preferably, the MACC1-AS1 probes are the double Digoxigenin labeled probes of MACC1-AS1.
According to the further feature of application of the present invention, the application is included by situ hybridization detection from tested
MACC1-AS1 dyeing scorings in sample, the MACC1-AS1 dyeing scoring are in patients with gastric cancer clinical prognosis and clinical stages
Positive correlation.
In the present invention, inventor carries out hybridization in situ experiment detection to the paraffin organization sample of 124 patients with gastric cancer
MACC1-AS1 expression quantity, and serial section row immunohistochemical staining is detected and positioned in MACC1 expression quantity and both tissues
Situation.As a result show, expression of the MACC1-AS1 in stomach organization is higher than cancer beside organism, and clinical stages is higher, TNM stage
Higher, MACC1-AS1 expressions are higher.Animal experiment is also prompted, and MACC1-AS1 can promote stomach cancer cell lung to shift.
In function assessment experiment, checking MACC1-AS1 is stripped off in glucose or is resisted apoptosis to stomach cancer cell during glucose low concentration, is maintained
The facilitation of propagation.The hybridization probe that above two parts test provable MACC1-AS1 is examined as patients with gastric cancer clinical prognosis
The substantial worth of test agent.It is horizontal in molecular mechanism, it have detected after sugar-free or low sugar, oxidative stress processing in stomach cancer cell line
MACC1-AS1 expression quantity changes, and have detected and joint is processed as above is overexpressed stomach cancer cell glycolysis relevant enzyme after MACC1-AS1
Expression changes and activity change, intracellular reducing substances (NADPH, GSH) content change and the change of cell generation ATP amount
Change.In stomach cancer cell experiment, the intracellular obvious increase of MACC1-AS1 expression after sugar-free or low sugar stimulation, while give anti-oxidant
Agent handles visible MACC1-AS1 without significant change.The stomach cancer cell after MACC1-AS1 processing is overexpressed in sugar-free or low sugar environment
Under can maintain multiplication capacity, apoptosis reduce.Above-mentioned molecules experiment can prove MACC1-AS1 in stomach cancer cell row glycolysis
The important function played during approach production capacity, it is to aid in stomach cancer cell and is under the conditions of the relative shortage of glucose, oxidative stress
The important molecule survived.It is understood that MACC1-AS1 is probably cell generation metabolism restructuring under regulation and control stressed condition
Key molecule.Therefore, the present invention judges that the detection probe of patients with gastric cancer prognosis provides theoretical foundation and clinical base for research
Plinth, so as to prove that MACC1-AS1 probes can predict the mechanism of patients with gastric cancer prognosis.
It is a further object to provide a kind of diagnostic kit for being used to predict stomach cancer clinical prognosis, the kit
Including MACC1-AS1 probes.According to the further feature of diagnostic kit of the present invention, the diagnostic kit is original position
Hybridization check kit.
The diagnostic kit is carried out according to the standard step of in situ hybridization kit.Main component is in kit
MACC1- AS1 probes, conventional ingredient are:40% deionized formamide, 10% glucan, 1 × Denhardt's, 0.02%
Ficoll, 0.02% polyvinylpyrrolidone (polyvinylpyrrolidone).Dye level is divided into 0 point of (colourless), 1
Divide (lavender (In situ hybridization)), 2 points (purples), 3 points (darkviolets), every kind of dyeing occupied area is then according to 0 point of (nothing
Cell dyeing), 1 point (25% dyeing), 2 points (50% dyeing), 3 points (75% dyeing) and 4 points (100% dyeing).Then dye
Depth scoring is added after being multiplied with the scoring of corresponding stained area, has both obtained last MACC1-AS1 dyeing scorings.Wherein 0-
2 points are defined as radiolucent table and reach, and 3-7 points are defined as weakly positive expression, and 8-12 points are defined as strong positive expression.Pass through calculating
MACC1-AS1 dyeing scorings, it is seen that the sensitivity of diagnosis of gastric cancer TNM stage is:52.63%, specificity is:63.53%, and comment
Divide higher patient's prognosis poorer.
It is related to clinical patients with gastric cancer prognosis the invention firstly discloses MACC1-AS1, with patient's TNM stage and clinical point
Phase is related.Animal experiment is also prompted, and MACC1-AS1 can promote stomach cancer cell lung to shift, while also demonstrate MACC1- first
Critical functions of the AS1 in stomach cancer cell glycolytic cycle, disclosing MACC1-AS1 has the mechanism of stomach cancer prognostic value.
Brief description of the drawings
Figure 1A is to detect MACC1-AS1 in stomach organization and the knot of cancer beside organism's expression difference by hybridization in situ technique
Fruit statistical chart.
Figure 1B is to be detected by hybridization in situ technique in different clinical stages patient cancerous tissues and cancer beside organism's section
MACC1- AS1 are expressed and distribution situation representative graph, multiplication factor:400.
Fig. 1 C are the MACC1-AS1 expression statistical results charts in different TNM groups.
Fig. 1 D are after serial section row immunohistochemical staining or in situ hybridization, are distributed in MACC1 and MACC1-AS1 tissues
Representative graph.
Fig. 1 E are MACC1 and MACC1-AS1 coexpressions situation statistical results chart, multiplication factor in serial section: 400、
1000。
Fig. 1 F-H are the Kaplan- of influence of the MACC1-AS1 different expressions to I-III phase patients with gastric cancer prognosis
Meier curve maps.
Fig. 1 I-K are the Kaplan-Meier curve maps of the prognostic analysis of IV phase Patients with Gastric Cancer, according to MACC1-AS with
Whether MACC1, which co-expresses, is grouped.
Fig. 1 L show table 1-1:MACC1-AS1 and MACC1 expression and the patients with gastric cancer relation with prognosis by stages.
Fig. 1 M show table 1-2:TNM I-III phases and the clinical case data of IV phases and MACC1-AS1 expression.
Fig. 2A-B are that nude mice tail vein injection is overexpressed lung's transfer stove after MACC1-AS1 stomach cancer cell line
Substantially representative graph and SABC representative graph.
Fig. 3 A are MACC1-AS1 structural representations.
Fig. 3 B are the PCR result statistical charts of MACC1-AS1 expression quantity in normal gastric epithelial cell and each stomach cancer cell line.
(#P<0.01)
Fig. 3 C are FISH and fluorescence immunization coloration result figure, show that MACC1-AS1 and MACC1 cell are default respectively
Position.Multiplication factor:3000.
Fig. 3 D are the caryoplasm distribution situations that MACC1-AS1 is expressed in round pcr detection stomach cancer cell.
Fig. 4 A-B are to give ROS (Reactive oxygen after sugar-free stimulation, N-acetylcystein processing stomach cancer cell
Species) testing result (+P<0.001).
Fig. 4 C-E are using sugar-free training base (C), H2O2(D, ROS derivant), 2-DG (E, 2-Deoxy-D- glucose, sugar
Glycolysis inhibitor) PCR detection MACC1-AS1 expression quantity changes after processing stomach cancer cell statistical results chart. (*P<0.05, #P<
0.01 ,+P<0.001)
Fig. 4 F are to give PCR detection MACC1-AS1 expression quantity change systems after sugar-free stimulation, N-acetylcystein processing stomach cancer cell
Count result figure.(#P<0.01)
Fig. 4 G are to give PCR detection MACC1-AS1 expression quantity change statistical results charts after low sugar training base culture stomach cancer cell. (#P<
0.01 ,+P<0.001)
Fig. 4 H are to give the horizontal change of Western blot detection glycolysis correlative protein expressions after low sugar training base culture stomach cancer cell.
Fig. 5 A are the PCR the result figures of the stomach cancer cell line for the overexpression MACC1-AS1 for transiently transfecting plasmid construction.
(+P<0.001)
Fig. 5 B are the result statistical charts for the survival condition that MACC1-AS1 cell lines are overexpressed under the conditions of MTT experiment detection sugar is deprived.
(+P<0.001)
Fig. 5 C are the overexpression MACC1-AS1 stomach cancer cell line colony formations under the low sugar training base culture of various concentrations
Result figure.
Fig. 5 D are to be overexpressed the multiple apoptosis-related protein Western blot representative graphs of MACC1-AS1 cell lines.
Fig. 5 E-F are the results that the MACC1-AS1 stomach cancer cell plant flow cytometer detection cell cycles are overexpressed after sugar-free stimulates
Figure.
Fig. 5 G-H be EDU (5-Ethynyl-2'-deoxyuridine) experiment detection sugar-free stress when be overexpressed MACC1-
AS1 stomach cancer cell line multiplication capacity result figures.(*P<0.05)
Fig. 5 I-J be flow cytometer detection sugar-free stress when be overexpressed MACC1-AS1 stomach cancer cell line apoptosis situation result figures.(*P<
0.05)
Fig. 6 A are that PCR experiment proves to be overexpressed glycolysis mRNA expression of gene associated situation knot in MACC1-AS1 stomach cancer cell lines
Fruit statistical chart.(*P<0.05)
Fig. 6 B-C displays are overexpressed glycolysis correlative protein expression situation in MACC1-AS1 stomach cancer cell lines, are Western
Blot (B) and immunofluorescence dyeing (C) result figure.Multiplication factor:1200.
Fig. 6 D-E are that sugar-free stimulates lower overexpression MACC1-AS1 stomach cancer cell lines 2-NBDG (2- [N- (7-nitrobenz-
2- oxa-1,3-diazol-4-yl) amino] -2-deoxy-D-glucose, glucalogue) intake flow cytometer detection knot
Fruit is schemed. (*P<0.05)
Fig. 6 F-G be sugar-free or low sugar processing after detection be overexpressed MACC1-AS1 stomach cancer cell lines ATP (F) and lactic acid (G) contain
Amount change statistical results chart.(*P<0.05 ,+P<0.001)
Fig. 6 H-I are to be overexpressed hexokinase activity (H) and lactic acid dehydrogenase activity (I) detection in MACC1-AS1 stomach cancer cell lines
As a result statistical chart.(*P<0.05)
Fig. 7 A are endocellular sugar glycolysis and pentose phosphate pathway metabolism schematic diagram.
Fig. 7 B are that sugar-free stimulates the lower testing result for being overexpressed MACC1-AS1 stomach cancer cell lines ROS quantitatively to scheme. (+P<
0.001)
Fig. 7 C-E are using sugar-free training base (C), H2O2(D, ROS derivant), 2-DG (E, 2-Deoxy-D-glucose, glycolysis
Inhibitor) detection inhibitory rate of cell growth statistical results chart after overexpression MACC1-AS1 stomach cancer cell lines is handled respectively.Wherein plus
It is positive controls to enter N-acetylcystein treatment group.(*P<0.05, #P<0.01 ,+P<0.001)
Fig. 7 F-G are that sugar-free stimulates lower MACC1-AS1 stomach cancer cell lines NADPH (F), the NADP+/NADPH (G) of being overexpressed to detect knot
Fruit statistical chart.(*P<0.05, #P<0.01 ,+P<0.001)
Fig. 7 H-I are that sugar-free stimulates lower overexpression MACC1-AS1 stomach cancer cell lines GSH (G), GSSG/GSH (H) testing result statistics
Figure.(#P<0.01)
Embodiment
Patient and tumor tissues sample
All experiments involved in the present invention are carried out under the license of Hospital of Southern Medical University Ethics Committee, institute
Some tumor tissues specimen samplings all have passed through patient's agreement.FFPE sample is derived from 124 patients with gastric cancer specimens from pri,
The time drew materials from 2004 to 2010.All patients included are classified according to the standards of AJCC 2010.
SABC and In situ hybridization
The article that team where the specific steps and dyeing points-scoring system of SABC can refer to inventor is delivered before this
(Wang,L.,et al.,Metastasis‐associated in colon cancer-1upregulation predicts
a poor prognosis of gastric cancer,and promotes tumor cell proliferation and
invasion.International Journal of Cancer,2013. 133(6):p.1419-1430.).In situ hybridization
Dyeing is carried out using the standard step of in situ hybridization kit.Immunohistochemical staining identifies MACC1 albumen, in situ hybridization mark
MACC1-AS1.The main component of in situ hybridization kit is MACC1-AS1 probes, is double Digoxigenin labeled probes,
Specifically nucleotide sequence is:5’ DigN/TCAATGCAGATCTAATACTCCT/3’Dig_N(SEQ ID NO:1).Conventional ingredient
For:Hybridization buffer:40% deionized formamide, 10% glucan, 1 × Denhardt's, 0.02%Ficoll, 0.02% gather
Vinylpyrrolidone (polyvinylpyrrolidone).Immunohistochemical staining uses MACC1 antibody to be purchased from Abcam companies
(San Francisco, California, the U.S.), HRP mark secondary antibodies are purchased from company of Zhong Shan Golden Bridge, and DAB staining kits are purchased from CWBIO
Company.
In situ hybridization step:It is first according in situ hybridization kit specification and carries out preparation of reagents.Will with slicer
The good tissue of FFPE is made the histotomy of about 4 μ m thicks, and 60 DEG C of roasting pieces 1 hour, (dimethylbenzene dewaxes for dimethylbenzene dewaxing
10min × 3 time, 100% ethanol 3min × 2 time, 95% ethanol 3min, it is placed in PBS and cleans × 2 times), section is dried, in
300 μ L Proteinase K Solution is added dropwise at tissue, histotomy is completely covered, is catalyzed 10 minutes in 37 DEG C, slide is placed in PBS
Middle termination, section dehydration (70% ethanol 1 minute, 95% ethanol 1 minute, 100% ethanol 1 minute), will cut into slices flat placement, drop
The hybrid mixed liquid (concentration and probe concentration 80nM) for adding 25 μ L to prepare, is placed in insulating box 50 DEG C 2 hours.SSC buffer solution for cleaning is cut into slices
(5 × SSC 5 divides × 1 time, and 1 × SSC 5 divides × 2 times, and 0.2 × SSC 5 divides × 3 times), confining liquid are incubated 15 minutes, are added dropwise
anti-DIG(1:800) reagent reacting 60 minutes, PBST clean × 3 times, 3 minutes every time, are added dropwise AP substrates NBT/BCIP, 30 DEG C
Lucifuge 2 hours, KTBT buffer solutions are incubated, terminating reaction.0.2% core fast red is redyed 2 minutes, and water rinses 10 minutes, section dehydration
(70% ethanol 5 divides × 2 times, and 95% ethanol 5 divides × 2 times, and 100% ethanol 5 divides × 2 times), mountant lid cover glass envelope is added dropwise
Piece, using just putting, light microscope is carried out observing film making and dyeing is scored.
Dye level is divided into 0 point (colourless), 1 point ((in situ hybridization contaminates for faint yellow (immunohistochemical staining), lavender
Color)), 2 points (yellow, purples), 3 points (brown color, darkviolets), it is every kind of dyeing occupied area then according to 0 point (acellular dyeing),
1 point (25% dyeing), 2 points (50% dyeing), 3 points (75% dyeing) and 4 points (100% dyeing).Then dye level scoring and
Corresponding stained area scoring is added after being multiplied, and has both obtained last MACC1 dyeing scorings.Wherein 0-2 points are defined as feminine gender
Expression, 3-7 points are defined as weakly positive expression, and 8-12 points are defined as strong positive expression.
Cell culture:Human Gastric carcinoma's cell line BGC803, BGC823, MKN45, SGC 7901, MGC 803 and normal gastric stick
Film epithelial cell line GES-1 is purchased from Foleibao (Shanghai, China).Cell training base is that RPMI 1640 trains base, wherein adding 10%
Hyclone, it is purchased from HyClone (Utah State, the U.S.).Condition of culture is 37 DEG C, 5%CO2.When building sugar-free stressed condition
Base 1640 is trained using sugar-free, purchased from GIBCO (U.S.).
Vector construction and transient transfection:It is to be expanded by Invitrogen companies by PCR to be overexpressed MACC1-AS1 plasmids
What MACC1-AS1cDNA, XbaI and EcoRI site were built after being subcloned.Transfecting the medium used is
The kits of Lipofectamine 2000, purchased from Invitrogen companies, operated according to specification in kit.
Slow-virus transfection:MACC1-AS1 is overexpressed slow virus by GeneChem companies (Shanghai, China) structure, with infection
Plural number 200 transfects two plants of stomach cancer cells of BGC803 and MKN45.After 1 μ g/mL puromycins screen 2 weeks, obtained by PCR checkings
Obtain the stable cell lines being overexpressed of MACC1-AS1.Above-mentioned steps are also used for building the stable silence strain stomach cancer cells of MACC1.
Zoopery:MACC1-AS1 stomach cancer cell lines MKN45 will be overexpressed with 5 × 105Quantity is injected 4 weeks through tail vein
In age nude mouse, injection gives disconnected neck to put to death after 6 weeks, takes out complete lung tissue and takes pictures and its FFPE, row HE are dyed and exempted from
Epidemic disease histochemical staining.
Immunoblotting (Western blot):The text that total protein of cell extraction is delivered before this according to inventor team
Chapter (Yang, T., et al., MACC1mediates acetylcholine-induced invasion and migration
by human gastric cancer cells.Oncotarget,2016)。
Use antibody:Abcam (Cambridge, Massachusetts, the U.S.) company:GLUT1, HK2 monoclonal antibody;
ImmunoWay (New York, Delaware state, the U.S.) company:GAPDH monoclonal antibodies;Proteintech Group (Chicago, she
Li Nuozhou, the U.S.) company:LDH, β-actin, histone H 3 monoclonal antibody;(Cambridge, Massachusetts are beautiful by Abclonal
State) company:Caspase3, BAX, CDK1, CDKN monoclonal antibody.The goat antirabbit secondary antibody of horseradish peroxidase-labeled and mountain
Sheep anti mouse secondary antibody is purchased from Bioss (Beijing, China).Protein level sxemiquantitative, β-actin and group are carried out using Image J softwares
Albumen H3 is internal reference.
RNA is extracted and real-time quantitative fluorescence PCR
Intracellular Total RNAs extraction is to use TRIZOL reagents (Invitrogen companies), and concrete operations flow is according to the description of product
Book.CDNA synthesis uses First Strand cDNA kits (Takara).Quantitative fluorescent PCR uses SYBR Green dye
Kit (being purchased from Roche, Peng Cibeige, Germany) is completed.The primer sequence is as shown in the table in experiment.Relative expression quantity with
SnRNA U6 or β-actin are with reference to progress 2-ΔΔCtComputing.
MACC1-AS1:
F-GCCAGTCAGAAAATGAGGAAC(21nt)
R-CCAGTTGGGTGAACAGGAC(19nt)
Glucose transporter-1 (GLUT1):
F-GGTTGTGCCATACTCATGACC(21nt)
R-CAGATAGGACATCCAGGGTAGC(22nt)
Hexokinase 2 (HK2):
F-TCCCCTGCCACCAGACTA(18nt)
R-TGGACTTGAATCCCTTGGTC(20nt)
Monocarboxylate transporter body 1 (MCT1):
F-CATGCCACCACCAGCGAAG(19nt)
R-TGACAAGCAGCCACCAACAATC(22nt)
6 glucose phosphate dehydrogenases (G6PD):
F-ACAGAGTGAGCCCTTCTTCAA(21nt)
R-GGAGGCTGCATCATCGTACT(20nt)
Beta-actin (β-actin):
F-TGGCACCCAGCACAATGAA(19nt)
R-CTAAGTCATAGTCCGCCTAGAAGCA(25nt)
U6:
F-CTCGCTTCGGCAGCACA(17nt)
R-AACGCTTCACGAATTTGCGT(20nt)
18s-RNA:
F-GCCCGAAGCGTTTACTTTGA(20nt)
R-TCCATTATTCCTAGCTGCGGTATC(24nt)
FISH and immunofluorescence dyeing
Synthesize Cy3 probes and be used for FISH to show MACC1-AS1, cell to be contaminated is through PBS after paraformaldehyde
(Suo Laibao companies, China) descending fixation in 15 minutes at room temperature of infiltration.Paraformaldehyde cleaning after, will training ware be placed on ice, in
Infiltrated 10 minutes in 0.5%Triton X-100, increase cell permeability.It is (wide according to Rui Bo companies after PBS cleans 3 times again
State, China) Fluorescent in Situ Hybridization kit specification row crossover process, hybridization environment be
The moist small interior of lucifuge, 37 DEG C 12 hours.Sodium citrate buffer solution (the saline- of series concentration is given in hybridization after terminating
Sodium citrate, SSC) cleaning.For display MACC1-AS1 and MACC1 common location situations, same ware cell is again through poly
After formaldehyde is fixed, 1%Triton solution is incubated 20min, and 30min is closed using 3%BSA solution.MACC1 primary antibody dilution ratio roots
Adjusted according to product description, 4 DEG C of overnight incubations of primary antibody.Afterwards, using fluorescence secondary antibody (being purchased from Beyotime, Chinese Shanghai) room temperature
1h is incubated, gives 4', 6- diamidinos -2-phenylindone (4', 6-diamidino-2-phenylindole, DAPI) dye nucleus.
Finally using Laser Scanning Confocal Microscope (Olympus Optical, Tokyo) observation shooting.
Nucleus cytoplasm rna and Protein Separation
Cell is on ice after PBS 3 times, according to PARIS kits (Life Technologies, Inc., Carlsbad, Jia Lifuni
Sub- state, the U.S.) specification operation.In simple terms, cell cracks through dissociating buffer (cell fractionation buffer)
Afterwards, it is incubated on ice 10 minutes, 4 DEG C of 500g are centrifuged 5 minutes, and it is cytoplasmic components that supernatant is taken after centrifugation, are added in remaining karyon composition
Enter clasmatosis buffer solution (cell disruption buffer)
Continue to crack, the cytosolic fractions of acquisition and karyon part carry out RNA and Protein Extraction according still further to specification, obtain product
Finally separating effect is verified through PCR and Western blot.
Metabolin, ROS and Enzyme assay
Cell to be measured is with 2 × 105The density kind in/hole is overexpressed MACC1-AS1 plasmids, sugar-free after 48 hours in six hole versions, transfection
Stimulation group will train base and be replaced by sugar-free training base, cultivate 12-24 hours, collects cell training base and is used to measure lactic acid concn (kit
Build up Bioengineering Research Institute purchased from Nanjing, China), cell through cracking be used to measuring ATP (kit is purchased from the green skies, Haimen,
China), Hexokinase 2 (hexokinase2, HK2) activity and lactic dehydrogenase (lactate dehydrogenase, LDH)
Activity (kit is purchased from Ke Ming Bioisystech Co., Ltd, Suzhou, China).ROS detections are (to be purchased from Nanjing according to kit
Bioengineering Research Institute is built up, China) specification operation, pass through fluorescence 2', 7'- dichlorofluorescein diacetate esters
(fluorescent 2 ', 7 '-dichlorofluorescin diacetate, DCF-DA) is detected.
NADP+/NADPH and GSH/GSSG detections
Cell to be measured is after 12 hours sugar-frees train base culture, after with pancreatin, cell is collected, according to NADP+/NADPH and GSH/
GSSG immue quantitative detection reagent boxes (being purchased from Biovision companies, California, the U.S.) interior specification is operated.
Apoptosis, survival rate and cell cycle detection
Apoptosis is carried out according to Annexin/PI kits (Kai Ji Bioisystech Co., Ltd, Nanjing, China) specification
Operation, is detected by stream type cell analyzer (BD Biosciences companies, San Jose, California, the U.S.).
Cell cycle is grasped according to cell cycle detection kit (Kai Ji Bioisystech Co., Ltd, Nanjing, China) specification
Make.Cell survival rate is that (5-Ethynyl-2'-deoxyuridine, 5- acetenyl -2- deoxidations are urinated by MTT experiment and EDU
Glycosides) operation is detected to specifications for experiment (kit is purchased from Rui Bo bio tech ltd, Guangzhou, China).
Colony formation
MACC1-AS1 stomach cancer cell line is overexpressed after stable transfection with 1 × 103The density in/hole is inoculated in 6 orifice plate culture 2 days,
Low sugar stimulation group is replaced by corresponding concentration of glucose training base and carries out culture 2 weeks.With PBS cell 2 times, fixed through paraformaldehyde
Afterwards, dyed with 0.5% crystal violet solution.Photographed to record after cleaning up.
Data analysis
All data analyses use GraphPad Prism softwares.T is examined and one-way ANOVA are examined for data in text
Comparative evaluation whether there is significant difference between group.Kaplan-Meier survivorship curves can survive between the displaying different grouping of image
The difference of time, significant difference are calculated by Wilcoxon rank tests.COX regression analyses are used to determine that patients with gastric cancer is pre-
Independent factor afterwards, event are defined as the death incident relevant with cancer.Spearman correlation analysis is used to calculate patients with gastric cancer
Clinical stages and the correlation degree of MACC1-AS1 dyeing scorings.Pearson correlation analyses be used for calculate MACC1-AS1 and
MACC1 coefficient of determination R2.P values think significant difference be present less than 0.05.
Reagent:2-deoxy-D-glucose (2-Deoxy-D-glucose, 2-DG), cycloheximide (Cycloheximide,
CHX), (Princeton, Massachusetts are beautiful purchased from MedChem Express companies for actinomycin D (Dactinomycin D)
State), MTT (3- (4,5-dimethylthiazol-2-yl) -2,5-diphenyl tetrazolium bromide, 3- (4,5-
Dimethylthiazole -2) -2,5- diphenyltetrazolium bromide bromides) purchased from lid skies Bioisystech Co., Ltd (Wuhan, China).2-
NBDG (2- [N- (7-nitrobenz-2-oxa-1,3-diazol-4-yl) amino] -2-deoxy-D-glucose, glucose
Analog) and DAPI (4 ', 6-diamidino-2-phenylindole, 4 ', 6- diamidinos -2-phenylindone) be purchased from
Invitrogen companies. H2O2, NAC (N-acetyl-L-cysteine, N-acetyl-L-cysteine) be purchased from Sigma-
Aldrich (U.S.);Living imaging fluorescein VivoGlo Luciferin are purchased from Promega companies (Madison, prestige
Si Kangxin states, the U.S.).PGEM-carrier T, T4DNA ligases, restriction enzyme SacII, SP6RNA Polymerase
It is purchased from Promega companies;Plasmid extraction kit and DNA purification kits purchase white TIANGEN;DIG marks the mark of cRNA probes
Remember kit, be Boehringer Mannheim Products.Other reagents have been mentioned above.
Embodiment one:MACC1-AS1 is high, and expression is related to patients with gastric cancer poor prognosis.
MACC1-AS1 expression quantity is carried out using in situ hybridization (ISH) to the paraffin organization sample of 124 patients with gastric cancer to comment
Estimate.As a result show, MACC1-AS1 is significantly higher than cancer beside organism (Figure 1A) in the expression quantity of stomach organization.With patient clinical by stages
Increase, MACC1-AS1 dyeing scoring also increase (Figure 1B).
According to MACC1-AS1 dye levels, all patients are divided into 3 groups, are negative group of (0~2 point), weakly positive group respectively
(3~7 points), strong positive group (8-12 points).In 124 patients with gastric cancer, a total of 8 negative patients, 116 are MACC1-
AS1 is positive, wherein 64 are weakly positive, 52 are strong positive.Using pathological diagnosis as goldstandard, it is seen that MACC1-AS1 double ground
The sensitivity of Gaoxin labeling nucleic acid probe diagnostics classifying gastric cancer TNM is:52.63%, specificity is:63.53%.(calculate public
Formula:Sensitivity=IV phase height expression number/IV phase total number of persons × 100%;Specificity=I-III phases are without expression and low expression people
Number/I-III phases total number of persons × 100%)
All patients respectively by T by stages, N by stages, M be grouped by stages, find MACC1-AS1 expression and T (P by stages<
0.001), N (P by stages<0.001), M (P by stages<0.001) and TNM stage is proportionate (Fig. 1 C).By carrying out serial section
MACC1 immunohistochemical stainings it is visible, MACC1-AS1 and MACC1 are into common location expression phenomenon (Fig. 1 D), and MACC1-AS1 tables
Up to amount and MACC1 positive correlations (R2=0.413, p<0.001) (Fig. 1 E).Kaplan- Meier survival analysises are visible, MACC1-
AS1 high expression DFS phase in the analysis of the subgroup of phase clinical stages I-III (Fig. 1 F-H) and IV phases patient (Fig. 1 I-K)
And Overall survival is shorter, MACC1-AS1 and MACC1 coexpression patient's prognosis is worse.Table 1-1:MACC1-AS1 and MACC1 table
Up to the patients with gastric cancer relation with prognosis by stages (see Fig. 1 L).Table 1-2:The clinical case data of TNM I-III phases and IV phases with
MACC1-AS1 expression (see Fig. 1 M).
According to above-mentioned clinical observation result, it is believed that MACC1-AS1 is related to patient's poor prognosis in stomach cancer.By
This proof, the stomach cancer sample of clinical biopsy or operation, after carrying out In situ hybridization by the standard step of in situ hybridization kit,
Scoring is dyed by the criterion calculation MACC1-AS1 in materials and methods, the higher patient's prognosis of scoring is poorer.
With reference to MACC1-AS1 gene locations and team to MACC1 the result of study in terms of glycometabolism, consider MACC1-AS1
Stomach cancer cell may be influenceed by glycometabolism to survive, it is then related to patient's prognosis.
Embodiment two:Experiment in vivo confirms that MACC1-AS1 remarkably promotes the transfer of stomach cancer cell lung
MACC1-AS1 stomach cancer cell lines MKN45 will be overexpressed with 5 × 105Quantity is injected in 4 week old nude mouses through tail vein, note
The neck that breaks after penetrating 6 weeks is put to death, and is taken out lung and is taken pictures (Fig. 2A) and by its FFPE, row HE dyeing and immunohistochemical staining, detection
MACC1, Ki67 (proliferative index) and 8-OHdG (oxidative stress index) (Fig. 2 B), as a result visible MACC1-AS1 be overexpressed
Group is larger relative to the lung's transfer stove quantity and volume of unloaded control group, and MACC1 and Ki67 expression are higher, and 8-OHdG expression is bright
It is aobvious to decline, illustrate that MACC1-AS1 promotes the transfer of stomach cancer cell lung, promote proliferation of human gastric cancer cell, resistance redox stress.
Embodiment three:Compared to normal gastric mucosa epithelial cell, MACC1-AS1 significantly high expression in stomach cancer cell.
According to ncbi database, determine that MACC1-AS1 is positioned at the antisense strand (Fig. 3 A) of MACC1 genes.By detecting just
MACC1-AS1 expression quantity in normal Gastric Mucosal Cells and more plants of stomach cancer cell lines, it can be found that to be expressed in stomach cancer thin for MACC1-AS1 height
In born of the same parents (Fig. 3 B).Choose two plants of stomach cancer cell lines of BGC803 and MKN45 therein and carry out subsequent experimental.
Because the positioning of lncRNA in the cell can aid in determining that it plays the mode of function, therefore row FISH
RNA performing PCRs are extracted to detect MACC1-AS1 distribution situations in stomach cancer cell after experiment (FISH) and caryoplasm separation, it is seen that
MACC1-AS1 is distributed mainly on cytoplasm (Fig. 3 C-D).Immunofluorescence dyeing is, it was also found that MACC1 and MACC1-AS1 is present altogether
Positioning phenomenon, kytoplasm (Fig. 3 C) is positioned at jointly.
Above-mentioned experimental result side, which reflects MACC1-AS1, may participate in MACC1 post-transcriptional level regulation and control, influence
MACC1 sugar-free stress when protective effect to cell.
Example IV:MACC1-AS expression increases in sugar is deprived and induces ROS build environments.
Streaming result verification, sugar deprive 0h, 6h, 12h ROS horizontal obvious increase, and the time is longer, and ROS levels are higher,
The level at corresponding time point ROS can fall after rise (Fig. 4 A-B) after addition antioxidant NAC.
PCR testing results are shown, are using sugar-free training base (Fig. 4 C), H2O2(ROS derivants, Fig. 4 D), 2- DG (2-
Deoxy-D-glucose, glycolytic inhibitor, Fig. 4 E) handle respectively stomach cancer cell 0,8,16, detect MACC1-AS1 after 24h
Expression quantity increase over time.Under low sugar condition of culture, MACC1-AS1 expression has also raised (Fig. 4 G).In order to visit
Whether rope is that ROS promotes increasing for MACC1-AS1 levels, gives sugar-free to stimulate, row after NAC (antioxidant) processing stomach cancer cells
PCR is detected, it is found that NAC can significantly reduce the MACC1-AS1 expression (Fig. 4 F) under sugar-free stimulates.Next research, sugar-free or low
Whether the MACC1-AS1 dramatically increased during sugar culture is related to glycometabolism, and then row Western blot are detected on protein level,
Low sugar stimulates lower glycolytic cycle key enzyme HK2, GLUT1 expression quantity increase (Fig. 4 H).
To sum up show, the MACC1-AS expression increase in the deprivation induced ROS build environments of sugar, and influence glycolysis correlation
Expression of enzymes.
Embodiment five:MACC1-AS1 can help the sugared apoptosis for depriving induction of stomach cancer cell resistance
For the function that clear and definite MACC1-AS1 is played in stomach cancer cell, construct MACC1-AS1 and be overexpressed plasmid, and it is right
Two plants of cells of BGC803 and MKN45 are transfected (Fig. 5 A).MTT experiment proves that under the conditions of sugar is deprived overexpression group cell is dead
Die considerably less than control group (Fig. 5 B).Probed into as influences of the MACC1-AS1 to the stomach cancer cell line long period, carry out clone's shape
Into experiment, it is also demonstrated that under low sugar condition of culture, overexpression group can form more bigger cell masses (Fig. 5 C).Next utilize
Western blot and flow cytomery Apoptosis and cell cycle situation of change, find overexpression group apoptosis correlation egg
White Cleaved caspase-3 and Bax expression reduces (Fig. 5 D), it is meant that MACC1-AS1 overexpression groups apoptosis is reduced.Streaming is thin
Under the conditions of born of the same parents' instrument is detected it is again seen that sugar deprives, the overexpression group S phases blocks reduces (Fig. 5 E-F) compared with control group, and apoptosis, which is reduced, (schemes
5I-J).Tested by EDU, it is found that MACC1-AS1 overexpressions group is survived in the case of sugar is deprived and proliferative conditions are better than control group
(Fig. 5 G-H).Cell function experimental result prompted MACC1-AS1 stomach cancer cell occur sugar-free stress when can maintain cell
Existence, reduce apoptosis.
Embodiment six:MACC1-AS1 promotes the survival of cell by glycolytic pathway.
PCR experiment find be overexpressed MACC1-AS1 stomach cancer cells in glycolysis related gene GLUT1, HK2, G6PD,
MCT1 expression quantity raises (Fig. 6 A).Western blot (Fig. 6 B) and immunofluorescence dyeing (Fig. 6 C) result are shown, are overexpressed
HK2, GLUT1, LDHA expression quantity raise in MACC1-AS1 MKN45, BGC803 cell.Sugar-free stimulates lower be overexpressed
MACC1-AS1 stomach cancer cell lines 2-NBDG (2- [N- (7-nitrobenz-2-oxa-1,3-diazol-4-yl) amino] -2-
Deoxy-D-glucose, glucalogue) intake substantially increases, and prompt MACC1-AS1 to increase grape cell Sugar intake
Ability (Fig. 6 D-E).
In order to further confirm that MACC1-AS1 is relevant with glycolytic cycle.Overexpression is detected after giving sugar-free or low sugar processing
The ATP (Fig. 6 F) and lactic acid (Fig. 6 G) content of MACC1-AS1 stomach cancer cell lines, it is found that ATP contains as concentration of glucose reduces
Amount rise, lactate level reduces, and is overexpressed MACC1-AS1 groups and is above control group.Meanwhile it is overexpressed MACC1-AS1 stomaches
Hexokinase activity (Fig. 6 H) and lactic acid dehydrogenase activity (Fig. 6 I) also raise in cancer cell.
In summary, it is believed that MACC1-AS1 promotes the survival of cell by glycolytic pathway.
Embodiment seven:MACC1-AS1 maintains cellular redox balance to give sugar by promoting glycolysis and producing NADPH
After depriving processing, the intracellular ROS of flow cytomery produces obvious increase, but the less (figure of overexpression group ROS incrementss
7B).(Fig. 7 C), H are stimulated when giving sugar-free respectively2O2(Fig. 7 D) and glycolytic inhibitor 2-DG (Fig. 7 E) handle stomach cancer cell,
The increase of visible cell growth inhibition ratio, and the similar NAC in the part increased suppression of effect control can be played by being overexpressed MACC1-AS1
Rate processed.
ROS is removed in the cell, and the one of method for saving growth inhibition ratio is increase polyphenoils such as NADPH
And GSH level.Then the NADPH and GSH of detection overexpression group and control group can have found after giving sugar-free stimulation:After sugar-free stimulates
NADPH is significantly reduced (Fig. 7 F), and NADP+/NADPH increased (Fig. 7 G), but overexpression group can substantially increase into the cell
NADPH, balance NADP+/NADPH ratios.Similar, MACC1-AS1 overexpressions group can also increase intracellular after sugar-free stimulates
GSH levels (Fig. 7 H), GSSG/GSH (Fig. 7 I) is reduced, to resist the cytotoxicity that sugar-free causes the ROS of intracellular accumulation.
To sum up result prompt, stomach cancer cell occur sugar-free stress when, MACC1-AS1 by produce polyphenoils mitigate
Toxicity of the ROS to cell, it may be possible to which MACC1-AS1 promotes stomach cancer cell that one of approach of glycolysis occurs.Integrated embodiment five
To seven, it was demonstrated that MACC1-AS1 be to aid in stomach cancer cell reply sugar-free stress important molecule, main path is by producing antioxygen
Compound maintains redox equilibrium and promotes glycolytic cycle.Hence it is demonstrated that MACC1-AS1 probes detect as stomach cancer prognosis
The theoretical foundation and mechanism of method.
In summary, significances of the present invention MACC1-AS1 clear and definite first as patients with gastric cancer clinical prognosis index,
The high expression of MACC1-AS1 by In situ hybridization and calculates MACC1-AS1 dyeing and commented predictive of the poor prognosis of patients with gastric cancer
Point, the higher patient's prognosis of scoring is poorer.Experiment in vivo confirms that the promotion that MACC1-AS1 shifts to stomach cancer cell lung is made
With.In cell function experiment and molecular mechanism experiment below, it was demonstrated that sugar-free or low sugar stress in the case of,
MACC1-AS1 is that reducing substances such as NADPH, GSH are to resist ROS cytotoxicity in stomach cancer cell by increasing, further
Promotion cell glycolysis metabolism is played to maintain the effect that energy supplies, to maintain the existence of stomach cancer cell and propagation, reduction is withered
Die.To sum up demonstrate the MACC1-AS1 mechanism related to stomach cancer prognosis.
The present invention proves MACC1-AS1 with patients with gastric cancer clinical prognosis and the positive correlation of clinical stages and its to stomach first
The prediction significance of cancer patient's poor prognosis, so as to use MACC1-AS1 double Digoxigenin labeled probes first, to stomach cancer group
Knit and cancer beside organism's row In situ hybridization.Scoring is dyed by the criterion calculation MACC1-AS1 in materials and methods, it is seen that diagnosis
The sensitivity of classifying gastric cancer TNM is 52.63%, specificity 63.53%, and higher patient's prognosis of scoring is poorer.Secondly, hair
Present stomach cancer cell experience sugar-free stress when MACC1-AS1 expression increases, and then find it can by increase intracellular NADPH,
GSH contents resist oxidative stress, promote glycolytic pathway energy supply, reduce apoptosis in gastric cancer.It can be inferred that in stomach cancer cell
In, MACC1-AS1 is the important molecule for safeguarding normal sugar metabolism, and demonstrates the reason for it is as stomach cancer prognostic marker.
Sequence table
<110>Hospital of Southern Medical University
<120>MACC1-AS1 probes are preparing the application in being used to predict the diagnostic reagent of stomach cancer clinical prognosis
<160> 1
<170> SIPOSequenceListing 1.0
<210> 1
<211> 22
<212> DNA
<213>Artificial sequence ()
<400> 1
tcaatgcaga tctaatactc ct 22
Claims (8)
1.MACC1-AS1 probes are preparing the application in being used to predict the diagnostic reagent of stomach cancer clinical prognosis.
2. application according to claim 1, it is characterised in that:The MACC1-AS1 probes include such as SEQ ID NO:1 institute
The nucleotide sequence shown.
3. application according to claim 1, it is characterised in that:The MACC1-AS1 probes are the double digoxin of MACC1-AS1
Labeling nucleic acid probe.
4. application according to claim 1, it is characterised in that:The application is included by situ hybridization detection from tested
MACC1-AS1 dyeing scorings in sample, the MACC1-AS1 dyeing scoring are in patients with gastric cancer clinical prognosis and clinical stages
Positive correlation.
A kind of 5. diagnostic kit for being used to predict stomach cancer clinical prognosis, it is characterised in that:Including MACC1-AS1 probes.
6. diagnostic kit according to claim 4, it is characterised in that:The MACC1-AS1 probes include such as SEQ ID
NO:Nucleotide sequence shown in 1.
7. diagnostic kit according to claim 4, it is characterised in that:The MACC1-AS1 probes are MACC1-AS1 double
Digoxigenin labeled probe.
8. diagnostic kit according to claim 4, it is characterised in that:The diagnostic kit is in situ hybridization detection examination
Agent box.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710983316.0A CN107641653B (en) | 2017-10-20 | 2017-10-20 | Application of MACC1-AS1 probe in preparation of diagnostic reagent for predicting clinical prognosis of gastric cancer |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710983316.0A CN107641653B (en) | 2017-10-20 | 2017-10-20 | Application of MACC1-AS1 probe in preparation of diagnostic reagent for predicting clinical prognosis of gastric cancer |
Publications (2)
Publication Number | Publication Date |
---|---|
CN107641653A true CN107641653A (en) | 2018-01-30 |
CN107641653B CN107641653B (en) | 2021-02-19 |
Family
ID=61124493
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710983316.0A Active CN107641653B (en) | 2017-10-20 | 2017-10-20 | Application of MACC1-AS1 probe in preparation of diagnostic reagent for predicting clinical prognosis of gastric cancer |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107641653B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109852696A (en) * | 2019-02-26 | 2019-06-07 | 南方医科大学南方医院 | Application of the DLC3 as gastric cancer prognostic marker |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102007223A (en) * | 2008-02-28 | 2011-04-06 | 俄亥俄州立大学研究基金会 | Microrna-based methods and compositions for the diagnosis, prognosis and treatment of gastric cancer |
CN103459597A (en) * | 2010-12-13 | 2013-12-18 | 社会福祉法人三星生命公益财团 | Marker for predicting stomach cancer prognosis and method for predicting stomach cancer prognosis |
US20140356868A1 (en) * | 2013-05-31 | 2014-12-04 | Charite - Universitaetsmedizin Berlin | Macc1 as a prognostic biomarker for hepatobiliary tumors |
CN104450615A (en) * | 2013-09-25 | 2015-03-25 | 深圳市北科生物科技有限公司 | Cell CTL (BiAT) with bispecific antibody as well as preparation method and application thereof |
CN105431738A (en) * | 2013-04-05 | 2016-03-23 | 延世大学校产学协力团 | Method for manufacturing gastric cancer prognosis prediction model |
CN106501516A (en) * | 2016-12-16 | 2017-03-15 | 南方医科大学南方医院 | A kind of reagent that assesses for postoperative gastric cancer prognosis and chemosensitivity and system |
CN106916211A (en) * | 2017-04-24 | 2017-07-04 | 南京盖斯夫医药科技有限公司 | The peptide inhibitor of MACC1 genes and application |
-
2017
- 2017-10-20 CN CN201710983316.0A patent/CN107641653B/en active Active
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102007223A (en) * | 2008-02-28 | 2011-04-06 | 俄亥俄州立大学研究基金会 | Microrna-based methods and compositions for the diagnosis, prognosis and treatment of gastric cancer |
CN103459597A (en) * | 2010-12-13 | 2013-12-18 | 社会福祉法人三星生命公益财团 | Marker for predicting stomach cancer prognosis and method for predicting stomach cancer prognosis |
CN105431738A (en) * | 2013-04-05 | 2016-03-23 | 延世大学校产学协力团 | Method for manufacturing gastric cancer prognosis prediction model |
US20140356868A1 (en) * | 2013-05-31 | 2014-12-04 | Charite - Universitaetsmedizin Berlin | Macc1 as a prognostic biomarker for hepatobiliary tumors |
CN104450615A (en) * | 2013-09-25 | 2015-03-25 | 深圳市北科生物科技有限公司 | Cell CTL (BiAT) with bispecific antibody as well as preparation method and application thereof |
CN106501516A (en) * | 2016-12-16 | 2017-03-15 | 南方医科大学南方医院 | A kind of reagent that assesses for postoperative gastric cancer prognosis and chemosensitivity and system |
CN106916211A (en) * | 2017-04-24 | 2017-07-04 | 南京盖斯夫医药科技有限公司 | The peptide inhibitor of MACC1 genes and application |
Non-Patent Citations (6)
Title |
---|
LIN WANG等: "Metastasis-associated in colon cancer-1 upregulation predicts a poor prognosis of gastric cancer, and promotes tumor cell proliferation and invasion", 《INTERNATIONAL JOURNAL OF CANCER》 * |
NAKAGAWA S., HIROSE T. 主编: "《Nuclear Bodies and Noncoding RNAs, Methods in Molecular Biology》", 5 December 2014, HUMANA PRESS, NEW YORK, NY * |
TING YANG等: "MACC1 mediates acetylcholine-induced invasion and migration by human gastric cancer cells", 《ONCOTARGET》 * |
佚名: "NR_046756.1", 《NCBI》 * |
李威等: "长链非编码RNA MACC1-AS1对乳腺癌细胞增殖和侵袭的影响", 《汕头大学医学院学报》 * |
苏式兵,许锦文 主编: "《生命科学前沿技术与中医药研究》", 30 September 2013, 上海浦江教育出版社 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109852696A (en) * | 2019-02-26 | 2019-06-07 | 南方医科大学南方医院 | Application of the DLC3 as gastric cancer prognostic marker |
Also Published As
Publication number | Publication date |
---|---|
CN107641653B (en) | 2021-02-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Huang et al. | Interleukin-8 induces expression of FOXC1 to promote transactivation of CXCR1 and CCL2 in hepatocellular carcinoma cell lines and formation of metastases in mice | |
US20060088532A1 (en) | Lymphatic and blood endothelial cell genes | |
Roberts et al. | Mechanisms of mechanical overload-induced skeletal muscle hypertrophy: current understanding and future directions | |
Zhang et al. | MiR-27a as a predictor for the activation of hepatic stellate cells and hepatitis B virus-induced liver cirrhosis | |
Zhu et al. | Apolipoprotein M promotes proliferation and invasion in non-small cell lung cancers via upregulating S1PR1 and activating the ERK1/2 and PI3K/AKT signaling pathways | |
CN104812898A (en) | Methods of treating a metabolic syndrome by modulating heat shock protein (hsp) 90-beta | |
CN110129447A (en) | Application of the PQBP1 in Diagnosis of Ovarian Cancer | |
CN109609653B (en) | The molecular marked compound and its application of diagnosis or treatment glioma | |
CN106520771B (en) | A kind of long non-coding RNA and its application in diagnosis/in treatment preeclampsia | |
Liu et al. | Long noncoding RNA LINC01133 confers tumor-suppressive functions in ovarian cancer by regulating leucine-rich repeat kinase 2 as an miR-205 sponge | |
CN113584173B (en) | Application of lncRNA SLC25A21-AS1 AS esophageal squamous cell carcinoma marker | |
CN107641653A (en) | MACC1 AS1 probes are preparing the application in being used to predict the diagnostic reagent of stomach cancer clinical prognosis | |
Wen et al. | Glucocorticoid and glycolysis inhibitors cooperatively abrogate acute graft-versus-host disease | |
CN107012256A (en) | Abdominal aneurvsm diagnosis and treatment mark | |
WO2011129427A1 (en) | Diagnostic agent and therapeutic agent for cancer | |
CN105247371A (en) | Treatment of insulin resistance through inhibitors of transcription factor TSC22D4 | |
CN107779503A (en) | The related difference expression gene of Alzheimer and its application | |
KR20200112743A (en) | Diagnosis and therapy of brain neurological disease using SGK3 gene | |
Binyu et al. | Endurance Training Inhibits the JAK2/STAT3 Pathway to Alleviate Sarcopenia | |
CN107385100A (en) | Purposes of the MCM8 as sdenocarcinoma of stomach Metastatic Marker | |
CN105145470A (en) | Construction method of mature adipose tissue beta-catenin knockout mouse model | |
CN107385099A (en) | Biomarker for diagnosis and treatment gastric gland metastasis of cancer | |
Huang et al. | Kaposi's sarcoma-associated herpes virus-derived microRNA K12–1 over-activates the PI3K/Akt pathway to facilitate cancer progression in HIV-related gastrointestinal Kaposi's sarcoma | |
CN117398404B (en) | Application of miRNA-141-5p in preparation of medicines for treating periodontitis diseases | |
Lee et al. | Relationship between MicroRNA signature and arterial stiffness in patients with ischemic stroke |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |